Tegsedi and Pantoprazole sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tegsedi (inotersen sodium) and Pantoprazole sodium (pantoprazole sodium). Common drug interactions include urinary occult blood positive among females and white blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Tegsedi and Pantoprazole sodium. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Tegsedi?

Tegsedi has active ingredients of inotersen sodium. eHealthMe is studying from 2,040 Tegsedi users. Check the latest studies of Tegsedi.

What is Pantoprazole sodium?

Pantoprazole sodium has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 66,892 Pantoprazole sodium users. Check the latest studies of Pantoprazole sodium.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

40 people who take Tegsedi and Pantoprazole sodium together, and have interactions are studied.

Tegsedi and Pantoprazole sodium drug interactions.

What are the common drug interactions of Tegsedi and Pantoprazole Sodium, by gender? *:

female:

Urinary occult blood positive
Nausea (feeling of having an urge to vomit)
Arthralgia (joint pain)
Urine leukocyte esterase positive
White blood cells urine positive
Adverse drug reaction
Ageusia (loss of taste functions of the tongue)
Dizziness postural
Fatigue (feeling of tiredness)
Headache (pain in head)

male:

White blood cell count decreased
Diarrhoea
Blood albumin decreased
Blood lactate dehydrogenase increased
Blood magnesium decreased
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Mean cell haemoglobin decreased (less than normal haemoglobin per red blood cell in a sample of blood)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Red cell distribution width increased

What are the common drug interactions of Tegsedi and Pantoprazole Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Adverse drug reaction
Fatigue (feeling of tiredness)
Headache (pain in head)
Influenza like illness
Injection site erythema (redness at injection site)
Nausea (feeling of having an urge to vomit)
Pain
Protein urine present
Visual impairment
Bacterial test positive

50-59:

Haematocrit decreased
Haemoglobin decreased
High density lipoprotein decreased
Lymphocyte count decreased
Malaise (a feeling of general discomfort or uneasiness)
Platelet count decreased
Platelet disorder
Protein urine present
Red blood cell burr cells present
Red blood cell count decreased

60+:

Platelet count decreased
Glomerular filtration rate decreased
Fungal test positive
Protein urine present
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Urinary occult blood positive
Diarrhoea
Arthralgia (joint pain)
Aspartate aminotransferase increased

What are the existing conditions these people have? *

Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 36 people, 90.00%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 3 people, 7.50%
High Blood Pressure: 3 people, 7.50%
Gout (uric acid crystals building up in the body): 3 people, 7.50%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 7.50%
Enlarged Prostate: 3 people, 7.50%
Type 2 Diabetes: 2 people, 5.00%
Peripheral Vascular Disorder: 2 people, 5.00%
Oedema (fluid collection in tissue): 2 people, 5.00%
Neuralgia (pain in one or more nerves): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tegsedi and Pantoprazole sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously